Key Insights

Highlights

Success Rate

83% trial completion

Published Results

33 trials with published results (22%)

Research Maturity

85 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.0%

18 terminated out of 150 trials

Success Rate

82.5%

-4.0% vs benchmark

Late-Stage Pipeline

14%

21 trials in Phase 3/4

Results Transparency

39%

33 of 85 completed with results

Key Signals

33 with results83% success18 terminated

Data Visualizations

Phase Distribution

115Total
Not Applicable (48)
Early P 1 (3)
P 1 (11)
P 2 (32)
P 3 (10)
P 4 (11)

Trial Status

Completed85
Terminated18
Unknown17
Recruiting15
Withdrawn8
Not Yet Recruiting3

Trial Success Rate

82.5%

Benchmark: 86.5%

Based on 85 completed trials

Clinical Trials (150)

Showing 20 of 20 trials
NCT05149573Not ApplicableRecruitingPrimary

Investigation of PEMF Therapy for Female Patients With IC/BPS

NCT05658874Phase 3TerminatedPrimary

A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain

NCT06013449Not ApplicableNot Yet RecruitingPrimary

Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations

NCT03844412Phase 2Completed

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

NCT02591199Phase 2TerminatedPrimary

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

NCT05127616Not ApplicableRecruiting

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

NCT05737121Phase 2RecruitingPrimary

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

NCT06394830Phase 2RecruitingPrimary

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

NCT06299683Not ApplicableRecruiting

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

NCT00124306Phase 3Completed

Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)

NCT06366269Not ApplicableRecruiting

Acupuncture First for IC/BPS

NCT00389142RecruitingPrimary

Identifying Genetic Causes of IC/BPS

NCT05726786Phase 3Recruiting

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

NCT05696444Not ApplicableActive Not Recruiting

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

NCT05699551Not ApplicableWithdrawnPrimary

Supervised Exercise as a Therapeutic Strategy for Interstitial Cystitis/Bladder Pain Syndrome

NCT06212661Enrolling By Invitation

Migraine Medication Effects on Urinary Symptoms

NCT04734106Early Phase 1RecruitingPrimary

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

NCT05062902Early Phase 1Not Yet RecruitingPrimary

A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management

NCT06096597Phase 2RecruitingPrimary

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

NCT03468530CompletedPrimary

Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients

Scroll to load more

Research Network

Activity Timeline